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E2, along with Erns and E1, is an envelope glycoprotein of Classical Swine Fever Virus (CSFV). E2 is
involved in several virus functions: cell attachment, host range susceptibility and virulence in natural
hosts. Here we evaluate the role of a speciﬁc E2 region, 818CPIGWTGVIEC828, containing a putative fusion
peptide (FP) sequence. Reverse genetics utilizing a full-length infectious clone of the highly virulent
CSFV strain Brescia (BICv) was used to evaluate how individual amino acid substitutions within this
region of E2 may affect replication of BICv. A synthetic peptide representing the complete E2 FP amino
acid sequence adopted a β-type extended conformation in membrane mimetics, penetrated into model
membranes, and perturbed lipid bilayer integrity in vitro. Similar peptides harboring amino acid
substitutions adopted comparable conformations but exhibited different membrane activities. Therefore,
a preliminary characterization of the putative FP 818CPIGWTGVIEC828 indicates a membrane fusion
activity and a critical role in virus replication.
Published by Elsevier Inc.
Introduction
Classical swine fever (CSF) is a highly contagious disease of
swine caused by CSF virus (CSFV), a small enveloped virus with
a positive-sense, single-strand RNA genome. CSFV is classiﬁed
as a member of the pestivirus genus within the Flaviviridae
family along with other viruses of economic importance, bovine
viral diarrhea virus (BVDV) and border disease virus (BDV)
(Becher et al., 2003). The approximately 12.5-kb CSFV genome
contains a single open reading frame that encodes a polypro-
tein composed of 3898 amino acids that ultimately yields up
to 12 ﬁnal cleavage products (NH2-Npro-C-Erns-E1-E2-p7-
NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH) through co- and post-
translational processing of the polyprotein by cellular and viral
proteases (Rice, 1996).
Structural components of the virion include the capsid (C) protein
and glycoproteins: Erns, E1 and E2. Erns, a secreted protein that
demonstrates RNAse activity and is loosely associated with the viral
envelope (Thiel et al., 1991; Weiland et al., 1990; Weiland et al., 1999),
does not have a hydrophobic transmembrane anchor domain. Erns
does, however, possess a C-terminal charged amphipathic segment
that can mediate translocation of Erns across bilayer membranes
(Langedijk, 2002). E1 and E2 are transmembrane proteins with an N-
terminal ectodomain and a C-terminal hydrophobic anchor (Thiel et
al., 1991). E2 is considered essential for CSFV replication, as virus
mutants containing partial or complete deletions of the E2 gene are
nonviable (van Gennip et al., 2002). E2 has been implicated, along
with Erns (Hulst and Moormann, 1997) and E1 (Wang et al., 2004), in
viral adsorption to host cells (Liang et al., 2003; van Gennip et al.,
2000). Modiﬁcations introduced into this glycoprotein appear to
have an important effect on CSFV virulence (Risatti et al., 2005, 2006,
2007a, 2007b; Van Gennip et al., 2004).
Using proteomic computational analysis, E2 has been charac-
terized as a truncated class II fusion protein (Garry and Dash,
2003). Although the overall structures of class I and II fusion
proteins are distinct, they may share structural/functional char-
acteristics in the parts of the molecules that interact with and
disrupt bilayer membranes. It is well established that class I fusion
proteins have a fusion peptide at the amino terminus of the
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molecule, or close to it, that is critical for fusion (Gallaher, 1987,
1996; Gallaher et al., 1989, 2001). Class II fusion proteins have an
internal FP that is located after secondary structural folding at
distal locations from the transmembrane anchor (Kuhn et al.,
2002; Lescar et al., 2001; Rey et al., 1995). Garry and Dash
described a putative FP located between amino acid residues
818–828 of CSFV E2. This putative FP contains a consensus
sequence with aromatic and hydrophobic residues located
between two cysteine residues. In addition, the FP is ﬂanked by
β sheets in class II fusion proteins. The cysteine residues as well as
the sequences in between are highly conserved among pesti-
viruses, as is true of class I and II FPs from other enveloped RNA
viruses (Garry and Dash, 2003). Recently the E2 protein of BVDV
has been crystallized, revealing a three β-domain structure
(El Omari et al., 2013). The putative FP appears to be partially
accessible on the surface of the protein. However, it does not form
a canonical fusion loop as those found in Class II proteins, which
suggests that other mechanisms-structures might operate in
pestivirus fusion.
Here we evaluate the role of a speciﬁc E2 region, 818CPIGWTG-
VIEC828, containing a putative FP sequence. Reverse genetics
utilizing a full-length infectious clone of the highly virulent strain
Brescia (BICv) was used to evaluate the role of individual as well as
combined amino acid substitutions in the replication of BICv. Only
double C818S/C828S or triple P819S/I820S/W822S substitutions
resulted in replication-deﬁcient viruses. Furthermore, we sought
to establish a correlation between the functional effects induced
by the amino acid substitutions and the capacity of synthetic FPs
for inserting into membranes and breach the permeability barrier.
At the outset we conﬁrmed the retention of β-type extended
conformations in membrane mimics for the native sequence and
its variants harboring the double C818S/C828S or triple P819S/
I820S/W822S substitutions. Our data indicate that amino acid
substitutions primarily affect the degree of FP penetration into
the lipid bilayer, the triple substitution resulting in shallower
insertion and reduced membrane activity. All in all, our results
suggest that the putative FP 818CPIGWTGVIEC828 is involved in
membrane fusion activity and plays a critical role in virus
replication.
Results
Location of the putative fusion peptide in the CSFV E2 protein
The putative E2 FP is formed by eleven amino acids situated
between positions 818 and 828 of the CSFV polypeptide. Compar-
ison of its amino acid sequence among different CSFV isolates
reveals 100% identity among isolates (Fig. 1). Compared to other
pestiviruses the amino acid identity ranges between 45 and 72%
similar to BVDV isolates with substitutions mostly occurring at
positions 820 and 825–827, 63–72% similar to BDV isolates with
amino acid substitutions at positions 820, 822, 824, 825, and 81%
similar to pestivirus giraffe-1 with substitutions at 823–825. This
high degree of conservation within each of the pestivirus sub-
groups, compared to the differences between the subgroups,
suggests the putative FP sequence may be involved in an impor-
tant viral function such as virus tropism.
Development of CSFV infectious clones harboring amino acid
substitutions in the FP sequence
To evaluate the role of the putative FP in the in vitro and in vivo
replication of CSFV as well as in the production of disease in swine,
a series of recombinant CSF viruses containing amino acid sub-
stitutions in the FP area were designed using the cDNA infectious
clone of the Brescia strain (BICv) as a template. A total of eight
cDNA constructs containing the amino acid substitutions
described in Table 1 were constructed.
Infectious RNA was in vitro transcribed from each mutated full-
length cDNA and used to transfect SK6 cells. Infectious virus
containing individual substitutions of C818S, C828S, P819S,
I820T, W822S or double substitution V825T/I826T was rescued
from transfected cells by day 4 post-transfection. Partial nucleo-
tide sequence of the rescued mutant E2 viruses was performed to
ensure the presence of the predicted mutations (data not shown).
Conversely, in three independent transfection events, con-
structs harboring a double, C818S/C828S, or triple, P819S/I820S/
W822S, substitutions were unvaryingly negative in terms of
recovering infectious particles (data not shown). Immunohisto-
chemistry analysis of transfected cell monolayers showed that
cells transfected with either construct C818S/C828S or P819S/
I820S/W822S expressed E2 (Fig. 2A) although at a decreased level
when compared to those found in cells transfected with the
constructs producing viable virus particles.
Thus, to determine if a gross defect in glycosylation of trun-
cated expression was at the origin of the lethal phenotype, the
expression of E2 glycoprotein in cells transfected with either
C818S/C828S or P819S/I820S/W822S was additionally analyzed
by Western blot. Cell extracts transfected with either of these two
constructs demonstrated signiﬁcant levels of E2 expression with a
product showing an electrophoretic mobility similar to that
observed with cell extracts transfected with an IC encoding for
the parental Brescia virus (Fig. 2B). These results suggest that the
double and triple substitution constructs produced a lethal repli-
cation virus phenotype, even though there is efﬁcient expression
of an apparently intact E2 product.
Replication of the CSFV FP mutants in vitro
in vitro replication characteristics of the FP E2 mutant viruses
containing individual (C818S, C828S, P819S, I820T, W822S) or
double substitutions (V825T/I826T) relative to parental BICv
were evaluated in a single-step growth curve. Primary swine
macrophage cell cultures were infected at a MOI of 0.01 TCID50
per cell. Viruses were adsorbed for 1 h (time zero), and samples
were collected at 72 h post-infection and titrated in SK6 cell
cultures. All mutant viruses exhibited growth kinetics almost
undistinguishable from that of the parental BICv (Fig. 3A).
Additionally, when the FP E2 mutant viruses' plaque sizes were
compared using SK6 cells, all mutants exhibited a plaque size
similar to that of the parental BICv (Fig. 3B). Therefore, indivi-
dual substitutions of most of the residues forming the putative
FP do not signiﬁcantly affect the ability of the virus to replicate
in cell cultures.
Virulence of CSFV FP mutants in vivo
To examine whether alterations of different residues included
in the putative E2 FP affect virulence, different groups of pigs were
intranasally inoculated with approximately 105 TCID50 of each of
the E2 FP mutant viruses (C818S, C828S, P819S, I820T, W822S,
V825T/I826T) and monitored for clinical disease, evaluated relative
to parental BICv. All animals infected with BICv presented clinical
signs of CSF starting 3–4 days post-infection (DPI), developing
classic symptoms of the disease and dying around 7–8 DPI
(Table 2). Total white blood cells, lymphocytes and platelet counts
dropped by 4–6 DPI in animals inoculated with BICv and con-
tinued declining until death (data not shown). All mutant viruses
presented a virulence phenotype almost indistinguishable from
that of the parental BICv (Table 2). All animals infected with these
viruses presented clinical signs of CSF starting at 3–5 DPI, with
clinical presentation and severity similar to those observed in
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animals inoculated with BICv. White blood cells, lymphocytes and
platelet counts dropped by 4 DPI and continued declining until
death (data not shown) at 6–9 DPI.
Viremia in animals inoculated with E2 FP mutants in general
accompanied the evolution of the clinical disease (data not
shown), exhibiting viremia kinetics almost undistinguishable from
that induced by parental BIC virus, presenting high titers that
remained until death of the animal.
Therefore, with the exception of the lethal substitutions C818S/
C828S or P819S/I820S/W822S, substitutions of any of the other
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Fig. 1. Sequence alignment to show putative FP sequences (highlighted) of E2 from different Pestiviruses (CSF, BVD, BD and Giraffe-1). Partial amino acid sequence
surrounding polypeptide residues 818–828 are presented.
Table 1
Nucleotide sequence of primers used for the production of E2FP recombinant viruses (only forward primers are presented).
Mutant name Forward primer sequence
C818S 50 GGTAGTGCATTCTACCTAGTTTGCCCAATAGGGTGGACGGGTGTT 30
C828S 50 GGGTGGACGGGTGTTATAGAGTGCACGGCAGTGAGCCCGACAACT 30
C818S/C828S a
P819S 50 AGTGCATTCTACCTAGTTTGCTCAATAGGGTGGACGGGTGTTATA 30
I820T 50 GCATTCTACCTAGTTTGCCCAACAGGGTGGACGGGTGTTATAGAG 30
W822S 50 TACCTAGTTTGCCCAATAGGGTCGACGGGTGTTATAGAGTGCACG 30
P819S/I820S/W822S 50 GCATTCTACCTAGTTTGCTCAACAGGGTCGACGGGTGTTATAGAGTGC 30
V825T/I826T 50 TGCCCAATAGGGTGGACGGGTGATACAGAGTGCACGGCAGTGAGCCCG 30
a Primers C818S and C828S were consecutively used to create mutant C818S/C828S.
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residues under study within the FP area do not signiﬁcantly affect
virus growth in cell culture or pathogenesis in swine.
Evaluation in vitro of the putative fusion peptide in terms of structure
and membrane interaction
To determine the effect of the amino acid substitutions on the
adopted conformations and the interactions with membranes,
three FP variant peptides were synthesized and comparatively
analyzed. One of the synthetic peptides represents the native
sequence of the E2 FP (designated as WT) while the other two
harbor a double (C818S/C828S) or a triple substitution (P819S/
I820S/W822S) and were designated as mut-1 and mut-2, respec-
tively (Fig. 4A). All three sequences were ﬂanked by additional
lysine residues to confer solubility, and tagged at the N-terminus
with the NBD ﬂuorescent probe for assessment of interactions
with lipid bilayers. The secondary structures adopted by these
synthetic peptides are displayed in Fig. 4B. Circular dichroism
measurements disclosed comparable amounts of β-type extended
structures that were predominant for the three variants, and
overall retained in the membrane-mimicking environments pro-
vided by SDS and DPC micelles. Thus, the amino acid substitutions
did not seem to affect the secondary structure of the E2 FP, which
otherwise performed comparably in solution and the low-polarity
membrane environment.
Membrane interactions of WT, mut-1 and mut-2 variants were
next assessed in lipid monolayer and unilamellar vesicle models
(Fig. 5). The three sequences were ﬁrst compared in the lipid
monolayer system, which allows monitoring peptide penetration
into membranes as an increase of the monolayer lateral pressure
(see Largo et al. 2014 for a description of the system). The system
also allows adjustment of the initial lateral pressure (π0). Thus, the
FP capacity of raising the monolayer lateral pressure upon injec-
tion at high π0s (i.e., with tightly packed phospholipids) will
correlate with its capacity for inserting into the viral target
membrane (Nieva and Agirre, 2003; Rafalski et al., 1990). Penetra-
tion levels of the synthetic FPs depending on π0 are shown in
Fig. 5A. The monolayer exclusion pressures, πex, or the maximum
initial lateral pressures at which membrane-association was
accompanied by peptide integration into the monolayer, were
Fig. 2. Expression of E2 glycoprotein in SK6 cells transfected with the indicated constructs (detection was performed using anti-E2 mAb WH303) by
(A) immunocytochemistry, and (B) Western blot.
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comparable for WT and mut-1, and consistent with their penetra-
tion into membranes with the lipid packing density existing at the
target cell membrane (πcZ30 mN/m, (Marsh, 2007). In contrast,
the mut-2 variant was unable to efﬁciently penetrate into mono-
layers compressed to those levels.
To determine degrees of association with lipid bilayers, we next
compared partitioning of the three sequences into vesicles by
monitoring changes in the emitted NBD-ﬂuorescence (Fig. 5B).
The partitioning coefﬁcients, estimated upon titrating the peptides
with increasing quantities of vesicles, were all in the range of 105,
therefore denoting comparable degrees of association for the three
variants. However, NBD intensity increased by a factor of 10 in the
case of the mut-1 peptide, while this factor was reduced to 3 for the
mut-2 peptide. The higher increase in emission intensity was
consistent with deeper penetration of the ﬂuorophore into the
hydrocarbon core of the lipid bilayer in the former case. The WT
NBD emission increased by a factor of 5, consistent with an inter-
mediate level of insertion. In summary, lipid monolayer and NBD-
ﬂuorescence results suggest that the triple substitution interferes
with FP penetration into the target membrane, while replacing the CC
residues results in deeper insertion into the low-polarity region.
Finally, results displayed in Fig. 5C revealed that WT inserted
into membranes was capable of perturbing the lipid bilayer
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Fig. 3. in vitro growth characteristics of FP mutants and parental BICv. (A) Primary swine macrophage cell cultures were infected (MOI¼0.01) with each of the FP virus
mutants or BICv and virus yield titrated at times post-infection in SK6 cells. Data represent means and standard deviations from two independent experiments. Sensitivity of
virus detection: Z1.8 TCID50/ml. (B) Plaque formation of the FP virus mutants and BICv. SK6 monolayers were infected, overlaid with 0.5% agarose and incubated at 37 1C for
3 days. Plates were ﬁxed with 50% (vol/vol) ethanol-acetone and stained by immunohistochemistry with mAb WH303.
Table 2
Swine survival and fever response following infection with E2FP mutants and
parental BICv.
Virus No. of
survivors/
total no.
Mean time
to death
(days7SD)
Fever
No. of days
to onset
(days7SD)
Duration
(days7SD)
BIC 0/4 7.75 (1.5) 3.75 (0.9) 5 (1.4)
C818S 0/4 7.25 (0.9) 4 (0.0) 4.25 (0.9)
C828S 0/4 6.75 (2.1) 4 (0.0) 3.75 (0.9)
P819S 0/4 7.75 (0.5) 5 (1.1) 4.75 (1.7)
W822S 0/4 9.5 (3) 5.5 (2.3) 4.75 (1.7)
V825T/
I826T
0/4 9.5 (2.3) 3.5 (1) 7 (2.1)
I820T 0/4 8.5 (2.1) 3.5 (0.7) 6 (1.4)
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architecture more efﬁciently than the mutant-representing pep-
tides. In these assays the integrity of the POPG membrane was
monitored using the ANTS/DPX assay (Nieva et al., 1994; Rafalski
et al., 1990). A peptide-to-lipid ratio of 1:700 was required to
induce 50% of vesicle permeabilization by WT, whereas the ratio
increased to 1:300 for mut-1 and this level of permeabilization
was barely attained with the highest dose of mut-2 tested (1:100).
Thus, for comparable amounts of peptide associated with the
membrane, the WT sequence was more efﬁcient than the mutants
at destabilizing the integrity of the vesicles.
Discussion
This report attempted to characterize the role of the putative FP
comprising the amino acid residues 818CPIGWTGVIEC828 of glycopro-
tein E2 in CSFV. Reverse genetics and an in vitro artiﬁcial membrane
assays were used to assess the role of individual residues within the
E2 FP in the process of virus replication and membrane insertion.
Double (C818S/C828S) or triple (P819S/I820S/W822S) residue sub-
stitutions completely abrogate virus replication, additionally, the triple
substitution led to a decreased capacity for membrane insertion.
The characterization of the structure and membrane interactions
of synthetic peptides representing the double and triple substitutions
in the FP indicated that the conformations adopted by the WT and
mutated peptides were compatible with the extended β-type struc-
ture of the FP. Such structures were not signiﬁcantly altered in the
presence of membrane mimetics, indicating the amino acid substitu-
tions did not affect the overall conformation adopted by the FP in
solution or the low-polarity membrane-like environment. In contrast,
the three peptides displayed different patterns of interactions with
membrane models. The ability of synthetic peptides and their mutant
variants to penetrate into POPG monolayers was earlier described for
the HIV-1 FP (Nieva et al., 1994; Rafalski et al., 1990). Those studies
demonstrated that a polar substitution that inactivated the fusion
glycoprotein also interfered with the penetration of the FP into the
POPG monolayer. In our experiments, the triple substitution (P819S/
I820S/W822S) had a comparable blocking effect on the ability of the
E2 FP. This mutant associated with POPG vesicles as efﬁciently as WT
and double substitutions, but induced therein less permeabilization.
Thus, we assume that the triple substitution causes a shallower
association with the lipid bilayer, a possibility supported by the more
polar environment sensed by the NBD ﬂuorescent probe. In this
regard, proline and tryptophan residues sustain insertion of the Ebola
virus FP as an integral membrane hairpin, and are required for the
fusogenic activity of the envelope glycoprotein. Structure and function
of the complete internal fusion loop from Ebola virus glycoprotein 2
(Gregory et al., 2011). By analogy, the lack of FP insertion induced by
the triple substitution might interfere with E2 fusogenic activity and
prevent CSFV infection. By comparison the peptide harboring the
double substitution inserted efﬁciently into monolayers and pene-
trated deeper into the lipid bilayer surrounding the vesicles (Nieva
and Agirre, 2003). In this case it is possible that a di-Sulﬁde bridge
stabilizing a functional integral haipin would be absent in the FP
mutant, thereby allowing its deeper insertion but hampering its
fusogenic activity. Nonetheless, this mutant was still less efﬁcient
than the WT at perturbing the membrane. It is postulated that the
membrane restructuring effect will be more potent for peptides
inserted at the level of the phospholipid glycerol backbone, than for
peptides associated at the level of the headgroups of the phospholi-
pids, or than for those inserted deeper into the acyl-chain region
(Nieva and Agirre, 2003). We infer that, compared to the mutant
derivatives, the WT peptide attains an intermediate depth of penetra-
tion to exert maximal lipid bilayer destabilization effects. This
observation would support its role as a membrane-destabilizing
anchor during fusion and explain its involvement in viral propagation.
Recently the E2 protein of BVDV has been crystallized, revealing a
three domain structure. Domains I and II are similar to Ig-like domains
and domain III is a series of three small β-sheet modules; this
structure is believed to be similar to CSFV E2 by prediction analysis
(Iourin et al., 2013; Li et al., 2013). Using the crystal structure for
BVDV-1 E2 at ph 8.0 (pdb:2yq2) (El Omari et al., 2013), the putative FP
appears to be partially accessible, however the critical residues P819S/
I820S/W822S appear to be mostly internal situated (Fig. 6). In
summary, this preliminary characterization of the functionality of
the putative FP comprising the amino acid residues 818CPIGWTG-
VIEC828 of glycoprotein E2 in CSFV demonstrated that altering this
area although do not signiﬁcantly alter protein expression, results
critical in the process of virus replication and the ability of the protein
to be inserted in cell membranes.
Materials and methods
Viruses and cells
Swine kidney cells (SK6) (Terpstra 1990), free of BVDV, were
cultured in Dulbecco's minimal essential media (DMEM) (Gibco,
Grand Island, NY) with 10% fetal calf serum (FCS) (Atlas Biologicals,
Fort Collins, CO). CSFV Brescia strain was propagated in SK6 cells
Fig. 4. Designation and structure of E2 FP-derived synthetic peptides. (A) Designation and sequences of the peptides used in this study. Substituted residues are indicated in
bold. (B) Secondary structures. The structural components were calculated for the CD spectra obtained in buffer (black bars), or in the presence of 100 mM DPC (white bars)
or 100 mM SDS (gray bars). Means7SD for the fraction values estimated with CONTIN-LL, CDSSTR and SELCON3 programs are plotted for the peptides as indicated in the
panels. H, helix; S, strand; TþU, turnsþunordered.
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and was used for the construction of an infectious cDNA clone
(Risatti et al., 2005). Growth kinetics was assessed using primary
swine macrophage cell cultures prepared as described by Zsak
et al. (1996). Titration of CSFV from clinical samples was per-
formed using SK6 cells in 96-well plates (Costar, Cambridge, MA).
After 4 days in culture, viral infectivity was assessed using an
immunoperoxidase assay utilizing the CSFV monoclonal antibody
WH303 (mAb WH303) (Edwards et al., 1991) and the Vectastain
ABC kit (Vector Laboratories, Burlingame, CA). Titers were calcu-
lated according to the method of Reed and Muench (1938) and
expressed as TCID50/ml. As performed, test sensitivity was
Z log10 1.8 TCID50/ml.
Construction of CSFV mutants
A full-length infectious clone (IC) of the virulent Brescia strain
(pBIC) (12) was used as a template to obtain all cDNA IC constructs
described in this report. Constructs containing mutations in the
FP area were obtained using the QuickChange XL Site-Directed
Mutagenesis kit (Stratagene) performed per manufacturer's
instructions using full-length pBIC as template and the primers
described in Table 1. The product was then digested with Dpn1,
leaving only the newly ampliﬁed plasmid, transformed into XL10-
Gold ultracompetent cells, and grown on Terriﬁc Broth Agar Plates
with ampicillin (Teknova). Positive colonies were selected for by
sequence analysis of the E2 gene and grown for plasmid puriﬁca-
tion using a Maxiprep kit (Qiagen Sciences, MD). Each of the IC
constructs were completely sequenced to verify that only site-
directed mutagenesis-induced changes were present.
in vitro rescue of CSFV Brescia and FP mutants
Full-length genomic clones were linearized with SrfI and
in vitro transcribed using the T7 Megascript system (Ambion,
Austin, TX) (Risatti et al., 2005). RNA was precipitated with LiCl
and transfected into SK6 cells by electroporation at 500 V, 720Ω,
100 W with a BTX 630 electroporator (BTX, San Diego, CA). Cells
were seeded in 12-well plates and incubated for 4 days at 37 1C
Fig. 5. Interactions with model membranes of E2 FP-derived synthetic peptides. (A) Penetration into POPG monolayers. Maximum increase in surface pressure induced upon
injection of 0.4 μM peptide into the subphase was measured as a function of the initial surface pressure of the phospholipid monolayers. Monolayer exclusion pressures are
indicated in the panels. The dotted line begins at 30 mN/m. (B) Partitioning curves as estimated from the fractional change in NBD-ﬂuorescence in the presence of increasing
amounts of POPG LUV. The solid lines correspond to the best ﬁttings of the experimental values to equation [1]. The estimated Kx values are displayed in the panels. (C) Final
extents of ANTS leakage (percentage after 30 min) from POPG LUV as a function of the lipid-to-peptide mole ratio. Lipid concentration (100 mM) was ﬁxed. The amount of
peptide bound to membrane was corrected according to the partition coefﬁcients in panel B. EC50 values are displayed in the panels.
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and 5% CO2. Virus was detected by immunoperoxidase staining as
described above, and stocks of rescued viruses were stored at
70 1C.
DNA sequencing and analysis
Full-length clones and in vitro rescued viruses were completely
sequenced with CSFV-speciﬁc primers by the dideoxynucleotide
chain-termination method (Sanger et al., 1977). Viruses recovered
from infected animals were sequenced in the region of the
genome that contained the desired mutations. Sequencing reac-
tions were prepared with the Dye Terminator Cycle Sequencing Kit
(Applied Biosystems, Foster City, CA). Reaction products were
sequenced on a PRISM 3730xl automated DNA sequencer (Applied
Biosystems). Sequence data was assembled using Sequencher 4.7™
software (Genes Codes Corporation, Ann Arbor, MI). The ﬁnal DNA
consensus sequence represented, on average, a three- or four-fold
redundancy at each base position.
Animal infections
Virulence of FP mutant viruses relative to BICv was initially
assessed in 10–12 weeks old, forty-pound commercial-breed pigs
inoculated intranasally (IN) with 105 TCID50 of each virus. Pigs
were randomly allocated into 7 groups of 4 animals each and were
inoculated with a FP virus mutant or BICv. Clinical signs (anorexia,
depression, purple skin discoloration, staggering gait, diarrhea and
cough) and changes in body temperature were recorded daily
throughout the experiment and scored as previously described
(Mittelholzer et al., 2000). Blood was collected at times post-
infection from the anterior vena cava into EDTA-containing tubes
(Vacutainer) for total and differential white blood cell counts
(performed using a Beckman Colter ACT, Beckman, Colter, CA)
and quantiﬁcation of viremia by virus titration as described above.
Peptides
Peptides representing the CSFV E2 FP (WT) and its derived
mutants (mut-1 and mut-2, sequences displayed in Fig. 2A) were
commercially synthesized (Thermo Scientiﬁc) and tagged with
the 7-nitrobenz-2-oxa-l,3-diazole-4 (NBD) ﬂuorophore at the
N-terminus. The puriﬁed peptides were dissolved in dimethyl
sulfoxide (DMSO, spectroscopy grade) and their concentrations
determined by the bicinchoninic-acid microassay (Pierce, Rock-
ford, IL, USA). Small, diluted aliquots (typically 20 μL, 1 mg/mL)
were stored frozen and were thawed only once, upon use.
1-palmitoyl-2-oleoylphosphatidylglycerol (POPG) was purchased
from Avanti Polar Lipids (Birmingham, AL). The 8-aminonaphtha-
lene-1,3,6-trisulfonic acid sodium salt (ANTS) and p-xylenebis
(pyridinium)bromide (DPX) were obtained from Molecular Probes
(Junction City, OR). Dodecylphosphocholine (DPC) was from Ana-
trace (Maumee, OH, USA).
Circular dichroism srudies
Circular dichroism (CD) measurements were obtained from a
thermally-controlled Jasco J-810 circular dichroism spectropolari-
meter calibrated routinely with (1S)-(þ)-10-camphorsulfonic acid,
ammonium salt. Samples consisted of lyophilized peptides dis-
solved at concentrations of 0.03 mM in 2 mM Hepes (pH 7.4)
buffer. Spectra were measured in a 1 mm pathlength quartz cell
initially equilibrated at 25 1C. Data were taken with a 1 nm
bandwidth at 100 nm/min speed, and the results of 20 scans were
averaged.
Lipid monolayer penetration
Changes in surface pressure were monitored as a function of
time in a ﬁxed-area circular trough (μTrough S system, Kibron,
Fig. 6. Location of putative FP into schematic representation of a tridimensional structure of BVDV E2 (El Omari et al., 2013). Critical cystines are presented in green, the PI.W
residues in blue, and the remainder of the fusion peptide in yellow. The N-terminus is colored red for orientation. (A) A ribbon model is shown with the fusion peptide
colored and the surrounding β-sheets are colored in orange (B) The location of the putative FP it is shown a space ﬁlling model.
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Helsinki) measuring 2 cm in diameter and with an aqueous
volume of 1 ml (5 mM Hepes, 100 mM NaCl (pH 7.4)). Lipids,
dissolved in chloroform, were spread over the surface and the
desired initial surface pressure (π0) was attained by changing the
amount of lipid applied to the air-water interface. Peptides were
injected into the subphase to a ﬁnal concentration of 0.4 μM with
a Hamilton microsyringe.
Lipid vesicle assays
Large unilamellar vesicles (LUV) made of POPG were prepared
according to the extrusion method in 5 mM Hepes, 100 mM NaCl
(pH 7.4) using membranes with a nominal pore-size of 0.1 mm.
Partitioning into membranes was evaluated by monitoring the
change in the emitted NBD-ﬂuorescence. Corrected spectra were
recorded using a FluoroMax-3 (Jobin Yvon Horiba, Longiumeau,
France) with excitation set at 460 nm and 2-nm slits. Partitioning
curves were subsequently computed from the fractional changes
in emitted NBD-ﬂuorescence when titrated with increasing lipid
concentrations. The apparent mole fraction partition coefﬁcients,
Kx(app), were determined by ﬁtting the experimental values to a
hyperbolic function:
F=F0 ¼ 1þ
½ðFmax=F0Þ1½L
Kþ½L ð1Þ
where [L] is the lipid concentration and K is the lipid concentration
at which the bound peptide fraction is 0.5. Therefore, Kx(app)¼[W]/
K where [W] is the molar concentration of water.
tlsb-0.009w?>Vesicle permeabilization was assayed by mon-
itoring the release to the medium of encapsulated ﬂuorescent
ANTS as described (Nieva et al., 1994). In brief, LUV containing
12.5 mM ANTS, 45 mM DPX, 20 mM NaCl and 5 mM Hepes were
obtained by separating the unencapsulated material by gel-
ﬁltration in a Sephadex G-75 column that was eluted with 5 mM
Hepes and 100 mM NaCl (pH 7.4). Fluorescence measurements
were performed by setting the ANTS emission at 520 nm and the
excitation at 355 nm. A cutoff ﬁlter (470 nm) was placed between
the sample and the emission monochromator. The baseline leak-
age (0%) corresponded to the ﬂuorescence of the vesicles at time 0,
while 100% leakage was the ﬂuorescence value obtained after
addition of Triton X-100 (0.5% v/v).
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